T2 Biosystems Announces Issuance of U.S. Patent for Direct
LEXINGTON, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and...
Source: globenewswire.com
📰 John Sperzel News
Page 4 - John Sperzel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Sperzel. Real-time updates on events, politics, business and more.
Chembio Q1 Revenues More Than Double
Despite the revenue gains, the company said that there is substantial doubt about its ability to continue operations into 2023.
Source: 360dx.com
T2 Biosystems Announces BARDA Exercise of Contract Option
Advances U.S. Clinical Trials for T2Biothreat and T2Resistance and Continued Development of Next-Generation Diagnostics for the Detection of Bloodstream...
Meagan Dominick John Sperzel Centers For Disease Biosystems Inc Us Department Of Health Human Services
Source: globenewswire.com
T2 Biosystems Q4 Revenues Down 10 Percent, Beat Wall Street Expectations
The company's revenues for full-year 2021 were up 55 percent, however, on strong sales of its sepsis test panels.
United States John Sperzel Human Service Biomedical Advanced Research Us Department Of Health Development Authority Wall Street
Source: genomeweb.com
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
11.01.2022 - LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and ... Seite 1
Source: wallstreet-online.de
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the ... T2 Biosystems, Inc.February 4, 2021 GMT Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis LEXINGTON, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-...
Source: apnews.com
Why T2 Biosystems Stock Soared Today
Shares of T2 Biosystems (NASDAQ:TTOO) jumped on Friday after the healthcare diagnostics specialist said its testing panel could detect the new strain of the coronavirus first identified in Brazil. As of 3:35 p.m. EST, its stock price was up more than 30%. So what T2 Biosystems has now confirmed that its T2SARS-CoV-2 Panel can detect many different coronavirus strains, including the variants first identified in the U.K., South Africa, and Brazil. A recent evaluation of more than 42,000 g...
Source: fool.com
T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus
T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus January 11, 2021 18:19 ET | Source: T2 Biosystems, Inc. T2 Biosystems, Inc. Lexington, Massachusetts, UNITED STATES Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the U.S. LEXINGTON, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ...
Source: globenewswire.com
Why T2 Biosystems Stock Is Soaring Today
Investors are excited about the prospects of the company's COVID-19 diagnostic test.
Source: fool.com